American scientists: The potential anti - coronary vaccine generated enough antibodies to defeat the virus

The vaccine, which was tested on rats at the University of Pittsburgh Medical School researchers, generated antibodies in what is thought to be “to neutralise the” virus within two weeks of its injection.

The study authors will now apply to the Food and Drug Administration to get approval before the first clinical trials on people expected in the next month, writes Independent, translate Periscope.

Scientists around the globe are competing in the development of a vaccine to protect people from the coronary, which has so far infected nearly 1 million people, from whom 50,000 of whom have died.

The first human evidence by a coronary vaccine was done in a laboratory in Seattle last month after a team of American researchers passed animal testing.

Tens of other teams worldwide have other potential developing vaccines.

But Pittsburgh research is the first to be published after being examined by scientists outside this institution. /Periscope